Dow Down 0.22% Nasdaq Up 0.14%

Merrimack Pharmaceuticals, Inc. (MACK)

-NasdaqGM
6.59 Up 0.22(3.45%) Aug 22, 4:00PM EDT
Prev Close:6.37
Open:6.37
Bid:6.30 x 100
Ask:6.75 x 600
1y Target Est:13.20
Beta:1.21
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:6.33 - 6.76
52wk Range:2.05 - 8.25
Volume:1,680,866
Avg Vol (3m):1,608,600
Market Cap:689.23M
P/E (ttm):N/A
EPS (ttm):-1.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for MACK

Comparison

Symbol% ChgMkt Cap
MACKUp 3.45%689.23M
IMMUUp 3.30%287.26M
LRUSFUp 1.78%58.10M
THLDDown 1.23%238.65M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.00
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.97
Quarterly EPS Est (Sep-14) :-0.26
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-1.17

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback